The gut microbiota is composed of thousands of different kinds of bacteria, archaea, fungus, and viruses, that produce a considerable number of compounds playing key roles in the intestine microecology and host homeostasis.
Investigators from all over the world have done a lot of delicate work to unravel the importance of the symbiosis of gut flora, and find that gut microorganisms are potential targets of many chronic diseases. The gut flora affects the health of the host throughout the whole lifespan at a full range of aspects, including crosstalk with host immune systems, helping with food digestion and nutrient metabolism, accelerating the pathogenic progress of all kinds of chronic illnesses, as well as triggering the burst of some acute infections. Microbiome research has gained more and more attention both by academic and industrial organizations, and their results and findings have greatly speeded up the development of this novel area. Gut microbial community and its related biomolecules are promising targets in therapeutic and diagnostic fields, a better understanding of this unseen "organ" can benefit the administration of our body and health, and monitoring of gut microbes is a pharma innovation direction.
CD Genomics has been focused our work on gut microbiome for years, aiming to provide the best services for our academic and industrial customers to achieve their success. CD Genomics serves and supports our global customers with the most comprehensive solutions in gut microbiome studies. You may gain a better understanding of your research from our solutions below. Don't hesitate to contact us if you need any of our assistance.
Gut Microbiome and Host Homeostasis | |||||
Gut Microbiota and Host Age Research | |||||
Gut Microbiota and Host Diet Research | |||||
Gut Microbiota and Immune System | |||||
Gut Microbiome and Diseases | |||||
Gut Microbiota and Gastrointestinal (GI) Diseases | |||||
Ulcerative Colitis | |||||
C. Difficile Infection (CDI) | |||||
Recurrent Clostridium Difficile Infection (RCDI). | |||||
Crohn's Disease | |||||
Chronic Constipation | |||||
Inflammatory Bowel Disease (IBD) | |||||
Irritable Bowel Syndrome (IBS) | |||||
Acute Diarrhea | |||||
Functional Bowel Disorders (FBD) | |||||
Celiac Disease | |||||
Other Gastrointestinal Disorders | |||||
Gut Microbiota and Metabolic Disorders | |||||
Obesity | |||||
Type II Diabetes | |||||
Adipose Tissue Inflammation | |||||
Alcoholic Liver Disease (ALD) | |||||
Alcoholic Steatohepatitis (ASH) | |||||
Nonalcoholic Fatty Liver Disease (NAFLD) | |||||
Nonalcoholic Steatohepatitis (NASH) | |||||
Cardiovascular Diseases (CVD) | |||||
Atherosclerosis | |||||
Other Metabolic Disorders | |||||
Gut Microbiota and Autoimmune Disorders | |||||
Hashimoto's Thyroiditis | |||||
Psoriasis | |||||
Multiple Sclerosis | |||||
Systemic Sclerosis | |||||
Sjögren's Syndrome | |||||
Systemic Lupus Erythematosus (SLE) | |||||
Antiphospholipid Syndrome (APS) | |||||
Arthritis | |||||
Rheumatoid Arthritis | |||||
Periodontal Diseases | |||||
Allergic Conditions | |||||
Atopic Dermatitis (AD) | |||||
T1DM | |||||
Primary Biliary Cholangitis | |||||
Autoimmune Hepatitis | |||||
Autoimmune Addison's Disease | |||||
Pneumonia | |||||
Other Autoimmune Disorders | |||||
Gut Microbiota and Mental Disorders | |||||
Autism | |||||
Anxiety | |||||
Depression | |||||
Bipolar Disorders | |||||
Schizophrenia | |||||
Parkinson's Disease | |||||
Chronic Fatigue Syndrome | |||||
Other Neurological Disorders | |||||
Gut Microbiota and Cancers | |||||
Colorectal Cancer | |||||
Liver Cancer | |||||
Breast Cancer | |||||
Gastric Cancer | |||||
Pancreatic Cancer | |||||
AIDS | |||||
Other Cancers | |||||
Gut Microbiota in Therapeutic and Diagnostic Research | |||||
Bacterial Macromolecules as Therapeutic Targets | |||||
Fecal Microbial Transplant (FMT) Research | |||||
Microbial-Derived Biomarkers Discovery | |||||
Microbial Fingerprints Research |
*For Research Use Only. Not for use in diagnostic procedures.